Clinical Trial Update: Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis. [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing retard phosphatidylcholine versus mesalazine for achieving remission in ulcerative colitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalazin (mesalazine)
• Retarded Phosphatidylcholine (phosphatidylcholine (retarded-release formulation))

Snippet

Sponsor: Heidelberg University | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: WITHDRAWN